We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Can Psychotherapy Reduce Sickness Absence?

This study is ongoing, but not recruiting participants.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01181635
First Posted: August 13, 2010
Last Update Posted: April 22, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Lovisenberg Diakonale Hospital
  Purpose
The purpose of this study is to examine if psychotherapy can reduce sickness absence.

Condition Intervention
Mental Disorders Behavioral: Psychotherapy

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Can Psychotherapy Reduce Sickness Absence?

Resource links provided by NLM:


Further study details as provided by Lovisenberg Diakonale Hospital:

Primary Outcome Measures:
  • Sickness absence [ Time Frame: Before, after and 6 months after treatment. ]
    Present status (working or sick).


Secondary Outcome Measures:
  • Psychiatric symptoms [ Time Frame: Before, after and 6 months after treatment. ]
    CORE-OM.

  • Quality of life (QALY) [ Time Frame: Before, after and 6 months after treatment. ]
    15 D


Estimated Enrollment: 400
Study Start Date: August 2010
Estimated Study Completion Date: December 2017
Estimated Primary Completion Date: May 2017 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Psychotherapy
Short-term pychotherapy and/or psychoeduchative courses.
Behavioral: Psychotherapy
Standard psychotherapy for psychiatric disorders.

Detailed Description:
Sickness absence due to psychiatric problems is considered a growing problem in Norway. Little research is done to examine if psychotherapy can reduce sickness absence. Since 2007 there is a government sponsored program in Norway (Raskere tilbake) aimed at reducing sickness absence. This study examines if psychotherapy within this program, delivered at an out-patient clinic, actually reduces sickness absence. Levels of absenteeism is measured before, after and 6 months after treatment. This is a quasi-experimental study, where the treatment-group will be compared with a statistical group in the general population, that is socio-demographical similar and has similar history of sickness absence but haven't been to treatment. Changes in levels of symptoms and quality of life will also be measured. The participants will be asked to describe their working environment, and this will be related to outcome-measures.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients receiving psychotherapy at Lovisenberg DPS/Raskere Tilbake

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01181635


Locations
Norway
Lovisenberg diakonale sykehus, Lovisenberg DPS
Oslo, Norway, 0440
Sponsors and Collaborators
Lovisenberg Diakonale Hospital
Investigators
Study Director: Torleif Ruud, dr.med Akershus universitetssykehus
  More Information

Responsible Party: Lovisenberg Diakonale Hospital
ClinicalTrials.gov Identifier: NCT01181635     History of Changes
Other Study ID Numbers: 2010/494 (REK)
First Submitted: August 12, 2010
First Posted: August 13, 2010
Last Update Posted: April 22, 2016
Last Verified: April 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Additional relevant MeSH terms:
Mental Disorders
Psychotic Disorders
Schizophrenia Spectrum and Other Psychotic Disorders